gynecologic oncology at asco 2018: olaparib and vistusertib, westin
Published 6 years ago • 393 plays • Length 1:06Download video MP4
Download video MP3
Similar videos
-
0:53
gynecologic oncology at asco 2018: ovarian cancer, jcog0602, onda
-
3:46
gynecologic oncology at asco 2018: open vs mis in cervical cancer, margul
-
1:11
gynecologic oncology at asco 2018: ovarian cancer, mito16b-mango ov2b-engot ov17, pignata
-
5:32
asco 2018: dr. westin sheds light on parp inhibitor abstracts in ovarian cancer
-
4:34
gynecologic oncology at asco 2021: upfront therapy in ovarian cancer
-
2:07
emerging therapies in gynecologic oncology at asco 2024
-
3:42
gynecologic oncology at asco 2022: athena–mono trial (rucaparib monotherapy) for ovarian cancer
-
3:23
gyn onc at asco 2016: ovarian cancer
-
7:57
gynecologic oncology highlights at asco20 #sgoatasco
-
0:52
society of gynecologic oncology 50th anniversary: shannon n. westin, md
-
5:01
gynecologic oncology at asco 2021: endometrial cancer
-
0:46
gynecologic oncology at asco 2022: subgroup analysis of keynote-826
-
4:25
gynecologic oncology at esmo congress 2021: randomised phase ii trial of olaparib
-
3:50
gynecologic oncology at asco 2022: tv pembro in first-line recurrent or metastatic cervical cancer
-
2:11
meet gynecologic oncologist shannon westin, m.d.
-
0:57
dr. westin on parp resistance in ovarian cancer
-
9:00
gynecologic oncology at asco 2021: cervical cancer outback trial
-
2:34
gynecologic oncology research at asco 2017: icon6 ovarian cancer trial
-
2:28
gyn onc at asco 2016: endometrial cancer